AI assistant
Sending…
Salarius Pharmaceuticals, Inc. — Director's Dealing 2019
Jul 24, 2019
35494_dirs_2019-07-23_dd45b1c2-666b-422f-8b53-c1f57a0c0511.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Salarius Pharmaceuticals, Inc. (SLRX)
CIK: 0001615219
Period of Report: 2019-07-19
Reporting Person: Chuang Pao-Yu (Controller)
More from Salarius Pharmaceuticals, Inc.
Proxy Solicitation & Information Statement
2026
Jun 4
Proxy Solicitation & Information Statement
2026
Jun 4
Regulatory Filings
2026
May 19
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 2
Regulatory Filings
2026
Apr 2
Declaration of Voting Results & Voting Rights Announcements
2026
Feb 25
Major Shareholding Notification
2026
Feb 17
Proxy Solicitation & Information Statement
2026
Jan 9
Regulatory Filings
2026
Jan 8